The questions people actually type into Google about the GLP-1 pills, answered by medication. For education only. Talk to your clinician before changing anything.
No - there is no FDA-approved tirzepatide pill in 2026. Per Drugs@FDA, tirzepatide is approved only as the injectable pens Zepbound® and Mounjaro®. Compounded oral and sublingual tirzepatide exist, but no published bioavailability data supports them. The FDA-approved oral GLP-1s are Foundayo™ (orforglipron) and Wegovy® tablets.
Sources: FDA prescribing information, peer-reviewed clinical trials and NIH literature · Updated August 2026
Licensed cliniciansRefund if not prescribedCancel anytime503A U.S. pharmacies
A compounded daily tablet acting on GIP and GLP-1 receptors
01What is oral tirzepatide?
A compounded oral tablet preparation of tirzepatide, prepared by a state-licensed US compounding pharmacy against a prescription written for you. Tirzepatide acts on two gut-hormone receptors, GIP and GLP-1. Compounded medications are not FDA-approved. FDA does not review compounded medications for safety, effectiveness or quality before marketing.
Plays on YouTube
02Is it the same as Zepbound® or Mounjaro®?
Same active molecule, different products. Zepbound® and Mounjaro® are FDA-approved weekly injections made by the manufacturer. A compounded oral tablet is prepared by a pharmacy for you and has not been reviewed by FDA for safety or effectiveness, and we make no equivalence claim between them.
Plays on YouTube
03How do I take it?
As directed on the label dispensed with your prescription, typically one tablet daily. Because oral and injectable routes absorb differently, doses are not interchangeable between them, and your clinician sets the schedule.
Plays on YouTube
04Why choose a tablet over the injection?
Practicality: no needles, no sharps container, no refrigeration. People who dread injections often stay more consistent with a tablet, and consistency is where results are made. Whether the route suits your history is your clinician’s call.
Plays on YouTube
05What are the common side effects?
The familiar GLP-1 class effects: nausea, constipation, diarrhoea, indigestion and fatigue, most often after dose increases, easing as your body adjusts. Tirzepatide as a class carries a boxed warning regarding thyroid C-cell tumors observed in rodents; your clinician screens your history before prescribing.
Plays on YouTube
06How much does it cost?
Through PinwellRx, compounded oral tirzepatide starts at $299 a month on the quarterly plan, with the clinician evaluation, ongoing care, messaging and shipping included. Insurance does not cover compounded preparations, so the price you see is the whole price.
Plays on YouTube
07How do I get it?
Complete a short intake. A licensed clinician reviews it and, if treatment is medically appropriate, writes the prescription; a licensed US pharmacy prepares and ships it. If it is not appropriate, they will tell you that instead, and you are refunded in full.
Plays on YouTube
Keep exploring
Questions on the other medications
Every therapy we offer has its own answer library, same format, same honesty. Films for the tablets are in production.
These films are educational drug-class content, not medical advice and not an offer of treatment. Compounded medications are not FDA-approved, and FDA does not review compounded medications for safety, effectiveness or quality before marketing. Prescription medications are available only following evaluation by a licensed clinician who determines that treatment is medically appropriate; availability varies by patient and state. PinwellRx is a telehealth platform, not a pharmacy, manufacturer or compounder. Individual results vary and outcomes are not guaranteed.
Trial results and label statements belong to the cited FDA-approved products and publications - they are not claims about compounded medications. Compounded medications are not FDA-approved.